Precision BioSciences (NASDAQ:DTIL) reported quarterly losses of $(0.75) per share which missed the analyst consensus estimate of $(0.66) by 15.38 percent. This is a 66.06 percent increase over losses of $(2.21) per share from the same period last year. The company reported quarterly sales of $10.838 million which beat the analyst consensus estimate of $4.050 million by 167.60 percent. This is a 37.27K percent increase over sales of $29.000 thousand the same period last year.